T-MAXIMUM's CAR-T Therapy MT027 Cleared by FDA for Brain Cancer Trials
T-MAXIMUM's CAR-T Therapy MT027 Receives FDA Clearance
On October 12, 2026, T-MAXIMUM PHARMACEUTICAL (
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.